ES506046A0 - Procedimiento de obtencion de nuevas xantinas con actividad farmacologica - Google Patents

Procedimiento de obtencion de nuevas xantinas con actividad farmacologica

Info

Publication number
ES506046A0
ES506046A0 ES506046A ES506046A ES506046A0 ES 506046 A0 ES506046 A0 ES 506046A0 ES 506046 A ES506046 A ES 506046A ES 506046 A ES506046 A ES 506046A ES 506046 A0 ES506046 A0 ES 506046A0
Authority
ES
Spain
Prior art keywords
xanthines
procedure
pharmacological activity
obtaining new
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES506046A
Other languages
English (en)
Other versions
ES8303412A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investigacion Tecnica y Aplicada SA
Original Assignee
Investigacion Tecnica y Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investigacion Tecnica y Aplicada SA filed Critical Investigacion Tecnica y Aplicada SA
Priority to ES506046A priority Critical patent/ES506046A0/es
Priority to FR8216580A priority patent/FR2514003A1/fr
Priority to IT68159/82A priority patent/IT1191214B/it
Priority to JP57173129A priority patent/JPS5872584A/ja
Priority to BE2/59858A priority patent/BE894597A/fr
Priority to GB08228432A priority patent/GB2107709A/en
Priority to DE19823237064 priority patent/DE3237064A1/de
Publication of ES8303412A1 publication Critical patent/ES8303412A1/es
Publication of ES506046A0 publication Critical patent/ES506046A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES506046A 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica Granted ES506046A0 (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ES506046A ES506046A0 (es) 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
FR8216580A FR2514003A1 (fr) 1981-10-06 1982-09-30 Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine
IT68159/82A IT1191214B (it) 1981-10-06 1982-10-01 Xantine con attivita' farmacologica processo di ottenimento di esse e composizioni farmaceutiche che le contengono
JP57173129A JPS5872584A (ja) 1981-10-06 1982-10-01 新規キサンチン誘導体、その製法ならびに抗アレルギ−剤
BE2/59858A BE894597A (fr) 1981-10-06 1982-10-05 Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques les contenant et leur utilisation en medecine humaine
GB08228432A GB2107709A (en) 1981-10-06 1982-10-05 Xanthines
DE19823237064 DE3237064A1 (de) 1981-10-06 1982-10-06 Pharmakologisch aktive xanthine, verfahren zu ihrer gewinnung und pharmazeutische zubereitungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES506046A ES506046A0 (es) 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica

Publications (2)

Publication Number Publication Date
ES8303412A1 ES8303412A1 (es) 1983-02-01
ES506046A0 true ES506046A0 (es) 1983-02-01

Family

ID=8483044

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506046A Granted ES506046A0 (es) 1981-10-06 1981-10-06 Procedimiento de obtencion de nuevas xantinas con actividad farmacologica

Country Status (7)

Country Link
JP (1) JPS5872584A (es)
BE (1) BE894597A (es)
DE (1) DE3237064A1 (es)
ES (1) ES506046A0 (es)
FR (1) FR2514003A1 (es)
GB (1) GB2107709A (es)
IT (1) IT1191214B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531085A1 (fr) * 1982-07-28 1984-02-03 Adir Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant
US4710572A (en) * 1986-07-30 1987-12-01 American Home Products Corporation Histamine H1 antagonists
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
GB0009479D0 (en) * 2000-04-17 2000-06-07 Cipla Limited Antihistaminic compounds
TWI268930B (en) * 2000-07-28 2006-12-21 Ing-Jun Chen Theophylline and 3-isobutyl-1-methylxanthine based N-7 substituted derivatives and pharmaceutical composition thereof
PT2159226T (pt) * 2007-03-29 2016-12-16 Joint-Stock Company Obninsk Chemical Pharmaceutical Company Agente anti-histamínico e antialérgico e um método para a produção do mesmo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1133989A (en) * 1964-12-08 1968-11-20 Chugai Pharmaceutical Co Ltd Theophylline derivatives, their salts and process for preparing the same
US4426383A (en) * 1980-09-04 1984-01-17 Eisai Co., Ltd. Theophylline and theobromine derivatives
EP0087810B1 (en) * 1982-03-02 1986-06-25 Eisai Co., Ltd. Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient

Also Published As

Publication number Publication date
BE894597A (fr) 1983-01-31
GB2107709A (en) 1983-05-05
ES8303412A1 (es) 1983-02-01
FR2514003A1 (fr) 1983-04-08
IT1191214B (it) 1988-02-24
DE3237064A1 (de) 1983-04-21
IT8268159A0 (it) 1982-10-01
JPS5872584A (ja) 1983-04-30

Similar Documents

Publication Publication Date Title
BR8206320A (pt) Aeronave
DE3272121D1 (de) Mecidal probe
IT8103530A0 (it) Lunetta autocentrante
BE893452A (fr) Rail de support
ES543011A0 (es) Un colector de ordeno
MX160825A (es) Neumatico mejorado de aviones
DK600485A (da) Theophyllin-retardpraeparat
MX164151B (es) Procedimiento de hidrogenacion
NO863329D0 (no) Farmakologisk virksom forbindelse.
FI832956A (fi) Foerfarande foer framstaellning av 3-fenoxi-1-azetidinkarboxiamider med farmakoligisk aktivitet
ES506046A0 (es) Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
JPS5592384A (en) Compound having pharmacological activity
DE3260690D1 (de) N-acetyl-beta-d-glucosaminides for determining n-acetyl-beta-d-glucosaminidase activity
ES517942A0 (es) Procedimiento de obtener alcaloides bisindolicos.
FI821874A0 (fi) Tak- eller vaeggkonstruktion
ES506904A0 (es) Procedimiento de obtencion de nuevos benzofuranildioxolanos con actividad farmacologica.
ES504202A0 (es) Procedimiento de obtencion de benzhidrilpiperazinas
RO89014A (ro) Procedeu pentru obtinerea ferocromului
DE3062034D1 (en) Adenine derivatives possessing pharmacological activity
ES506094A0 (es) Procedimiento de obtencion de un derivado de guanina con ac-tividad antivirasica
ATA158986A (de) Fluggeraet
RO79237A2 (ro) Procedeu de obtinere a unui polipeptid
ES536112A0 (es) Procedimiento de obtencion de moldes
ES504460A0 (es) Procedimiento de obtencion de 2-bromo-alfa-ergocriptina
RO81963A2 (ro) Procedeu pentru obtinerea poliesterilor